HomeOSE • EPA
add
Ose Immunotherapeutics SA
Previous close
€5.51
Day range
€5.04 - €5.55
Year range
€4.51 - €11.58
Market cap
112.98M EUR
Avg Volume
127.40K
P/E ratio
3.48
Dividend yield
-
Primary exchange
EPA
In the news
Financials
Income Statement
Revenue
Net income
| (EUR) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 431.00K | -0.81% |
Operating expense | 10.23M | 97.59% |
Net income | -9.86M | -77.06% |
Net profit margin | -2.29K | -78.50% |
Earnings per share | — | — |
EBITDA | -7.09M | -52.30% |
Effective tax rate | 5.52% | — |
Balance Sheet
Total assets
Total liabilities
| (EUR) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 16.74M | -10.32% |
Total assets | 123.96M | 51.07% |
Total liabilities | 60.15M | 1.81% |
Total equity | 63.81M | — |
Shares outstanding | 21.86M | — |
Price to book | 1.89 | — |
Return on assets | -19.75% | — |
Return on capital | -22.27% | — |
Cash Flow
Net change in cash
| (EUR) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -9.86M | -77.06% |
Cash from operations | -8.98M | -123.42% |
Cash from investing | 4.00M | 1,397.41% |
Cash from financing | 419.50K | -93.18% |
Net change in cash | -4.56M | -349.37% |
Free cash flow | -4.34M | -93.82% |
About
Founded
Nov 17, 2004
Website
Employees
52
